← Insulin × glycemic control

TrialAnnals of internal medicine2008

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Katherine Esposito et al.PubMed ↗Publisher ↗

What the trial testedas reported · 116 people · 2008

Range includes no effect

No clear effect on glycemic control

+1.00percentage points−0.90 to +3.00

As reported

difference 1.0 percentage point, 95% CI −0.90 to 3.00

Range includes no effect

No clear effect on glycemic control

+2.00percentage points−1.10 to +5.00

As reported

difference 2.0 percentage points, 95% CI −1.10 to 5.00

Range includes no effect

No clear effect on hypoglycaemia

+7.00percentage points−5.00 to +13.0

As reported

difference 7 percentage points, 95% CI −5.00 to 13.0

Three numbers in the abstract

the abstract, start to end

… patients receiving glargine (difference, 2.0 percentage points [CI, -1.1 to …

… patients receiving glargine (difference, 1.0 percentage point [CI, -0.9 to …

… patients receiving glargine (difference, 7 percentage points [CI, -5 to 13 …

← favours treatmentfavours comparator →
could be chance
Glycemic control
2.0−1.10 to 5.00
Glycemic control
1.0−0.90 to 3.00
Hypoglycaemia
7−5.00 to 13.0
InsulinGlycemic controlHypoglycaemia
1 / 4

19 papers cite it

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 18936501